cordycepin has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Gong, Y; Huang, Y; Jin, P; Li, C; Luo, C; Misilimu, D; Wang, K; Wei, P; Wen, H | 1 |
| He, Y; Liu, Y; Si, Z; Wang, A; Wang, D; Wang, K; Xu, S; Yuan, J; Zhang, S | 1 |
2 other study(ies) available for cordycepin and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries, Traumatic; Deoxyadenosines; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; Neuroprotection; Neuroprotective Agents; Neutrophil Infiltration | 2021 |
Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats.
Topics: Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Deoxyadenosines; Disease Models, Animal; Dose-Response Relationship, Drug; Interleukin-10; Interleukin-1beta; Matrix Metalloproteinase 9; NADPH Oxidases; Neuroprotective Agents; Nitric Oxide Synthase Type II; Occludin; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2016 |